Spurred by Gottlieb, FDA on track to the most generic drug OKs ever in 1 year
A little more than eight months into 2017 and the FDA is on pace to break its record for abbreviated new drug application — or ANDA …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
